These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 24008606)
21. Effect of polyphenolic extract, Pycnogenol, on the level of 8-oxoguanine in children suffering from attention deficit/hyperactivity disorder. Chovanová Z; Muchová J; Sivonová M; Dvoráková M; Zitnanová I; Waczulíková I; Trebatická J; Skodácek I; Duracková Z Free Radic Res; 2006 Sep; 40(9):1003-10. PubMed ID: 17015282 [TBL] [Abstract][Full Text] [Related]
22. The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress. Belcaro G; Dugall M; Ippolito E; Hu S; Saggino A; Feragalli B J Neurosurg Sci; 2015 Dec; 59(4):437-46. PubMed ID: 26635191 [TBL] [Abstract][Full Text] [Related]
23. Improvement of signs and symptoms of chronic venous insufficiency and microangiopathy with Pycnogenol: a prospective, controlled study. Cesarone MR; Belcaro G; Rohdewald P; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Ippolito E; Fano F; Dugall M; Cacchio M; Di Renzo A; Hosoi M; Stuard S; Corsi M Phytomedicine; 2010 Sep; 17(11):835-9. PubMed ID: 20579863 [TBL] [Abstract][Full Text] [Related]
24. Treatment of melasma with Pycnogenol. Ni Z; Mu Y; Gulati O Phytother Res; 2002 Sep; 16(6):567-71. PubMed ID: 12237816 [TBL] [Abstract][Full Text] [Related]
25. A randomised, double-blind, placebo-controlled trial on the effect of Pycnogenol on the climacteric syndrome in peri-menopausal women. Yang HM; Liao MF; Zhu SY; Liao MN; Rohdewald P Acta Obstet Gynecol Scand; 2007; 86(8):978-85. PubMed ID: 17653885 [TBL] [Abstract][Full Text] [Related]
26. Supplementary management with Pycnogenol® in patients with lupus vasculitis in remission phases: a pilot, concept registry study. Cesarone MR; Belcaro G; Corsi M; Scipione C; Scipione V; Hu S; Hosoi M; Ledda A; Feragalli B; Cotellese R Minerva Cardioangiol; 2020 Apr; 68(2):146-152. PubMed ID: 32429631 [TBL] [Abstract][Full Text] [Related]
27. No beneficial effects of pine bark extract on cardiovascular disease risk factors. Drieling RL; Gardner CD; Ma J; Ahn DK; Stafford RS Arch Intern Med; 2010 Sep; 170(17):1541-7. PubMed ID: 20876405 [TBL] [Abstract][Full Text] [Related]
28. Pycnogenol: a blend of procyanidins with multifaceted therapeutic applications? D'Andrea G Fitoterapia; 2010 Oct; 81(7):724-36. PubMed ID: 20598812 [TBL] [Abstract][Full Text] [Related]
29. Pycnogenol, French maritime pine bark extract, improves endothelial function of hypertensive patients. Liu X; Wei J; Tan F; Zhou S; Würthwein G; Rohdewald P Life Sci; 2004 Jan; 74(7):855-62. PubMed ID: 14659974 [TBL] [Abstract][Full Text] [Related]
30. Pycnogenol Weichmann F; Rohdewald P Front Nutr; 2024; 11():1389374. PubMed ID: 38757130 [TBL] [Abstract][Full Text] [Related]
31. The effects of Pycnogenol on DNA damage in vitro and expression of superoxide dismutase and HP1 in Escherichia coli SOD and catalase deficient mutant cells. Kim YG; Park HY Phytother Res; 2004 Nov; 18(11):900-5. PubMed ID: 15597332 [TBL] [Abstract][Full Text] [Related]
32. Review on Sustained Relief of Osteoarthritis Symptoms with a Proprietary Extract from Pine Bark, Pycnogenol. Rohdewald PJ J Med Food; 2018 Jan; 21(1):1-4. PubMed ID: 28836883 [TBL] [Abstract][Full Text] [Related]
33. The antioxidant and antigenotoxic effects of pycnogenol(®) on rats treated with cisplatin. Aydin B; Unsal M; Sekeroglu ZA; Gülbahar Y Biol Trace Elem Res; 2011 Sep; 142(3):638-50. PubMed ID: 20676799 [TBL] [Abstract][Full Text] [Related]
34. Effects of the antioxidant Pycnogenol on cellular redox systems in U1285 human lung carcinoma cells. Gandin V; Nyström C; Rundlöf AK; Jönsson-Videsäter K; Schönlau F; Hörkkö J; Björnstedt M; Fernandes AP FEBS J; 2009 Jan; 276(2):532-40. PubMed ID: 19077163 [TBL] [Abstract][Full Text] [Related]
35. Treatment of ADHD with French maritime pine bark extract, Pycnogenol. Trebatická J; Kopasová S; Hradecná Z; Cinovský K; Skodácek I; Suba J; Muchová J; Zitnanová I; Waczulíková I; Rohdewald P; Duracková Z Eur Child Adolesc Psychiatry; 2006 Sep; 15(6):329-35. PubMed ID: 16699814 [TBL] [Abstract][Full Text] [Related]
36. Distribution of Constituents and Metabolites of Maritime Pine Bark Extract (Pycnogenol Mülek M; Seefried L; Genest F; Högger P Nutrients; 2017 Apr; 9(5):. PubMed ID: 28452960 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of the effects of supplementation with Pycnogenol® on fitness in normal subjects with the Army Physical Fitness Test and in performances of athletes in the 100-minute triathlon. Vinciguerra G; Belcaro G; Bonanni E; Cesarone MR; Rotondi V; Ledda A; Hosoi M; Dugall M; Cacchio M; Cornelli U J Sports Med Phys Fitness; 2013 Dec; 53(6):644-54. PubMed ID: 24247188 [TBL] [Abstract][Full Text] [Related]
38. Comparative study of Venostasin and Pycnogenol in chronic venous insufficiency. Koch R Phytother Res; 2002 Mar; 16 Suppl 1():S1-5. PubMed ID: 11933130 [TBL] [Abstract][Full Text] [Related]
39. Accelerated antioxidant bioavailability of OPC-3 bioflavonoids administered as isotonic solution. Cesarone MR; Grossi MG; Di Renzo A; Errichi S; Schönlau F; Wilmer JL; Lange M; Blumenfeld J Phytother Res; 2009 Jun; 23(6):775-7. PubMed ID: 19172583 [TBL] [Abstract][Full Text] [Related]
40. A review on biological, nutraceutical and clinical aspects of French maritime pine bark extract. Maimoona A; Naeem I; Saddiqe Z; Jameel K J Ethnopharmacol; 2011 Jan; 133(2):261-77. PubMed ID: 21044675 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]